These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20950580)

  • 21. Antivenom: the most cost-effective treatment in the world?
    Brown N; Landon J
    Toxicon; 2010 Jun; 55(7):1405-7. PubMed ID: 20171241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms.
    Ros-Lucas A; Bigey P; Chippaux JP; Gascón J; Alonso-Padilla J
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti snake venom crisis in Africa: a suggested manufacturers product guide.
    Simpson ID; Blaylock RS
    Wilderness Environ Med; 2009; 20(3):275-82. PubMed ID: 19737031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The global snakebite crisis--a public health issue misunderstood, not neglected.
    Simpson ID; Norris RL
    Wilderness Environ Med; 2009; 20(1):43-56. PubMed ID: 19364169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
    Laustsen AH; Johansen KH; Engmark M; Andersen MR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardization of regional reference for mamushi (Gloydius blomhoffii) antivenom in Japan, Korea, and China.
    Fukuda T; Iwaki M; Hong SH; Oh HJ; Wei Z; Morokuma K; Ohkuma K; Dianliang L; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2006 Feb; 59(1):20-4. PubMed ID: 16495629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of snake bite.
    Reid HA; Theakston RD
    Bull World Health Organ; 1983; 61(6):885-95. PubMed ID: 6609008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Envenomation by exotic snakes].
    Aubert M; De Haro L; Jouglard J
    Med Trop (Mars); 1996; 56(4):384-92. PubMed ID: 9139199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antivenoms for the treatment of snakebite envenomings: the road ahead.
    Gutiérrez JM; León G; Burnouf T
    Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.
    Soopairin S; Patikorn C; Taychakhoonavudh S
    PLoS One; 2023; 18(7):e0288723. PubMed ID: 37467278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Snakebite envenomation and death in the developing world.
    Cruz LS; Vargas R; Lopes AA
    Ethn Dis; 2009; 19(1 Suppl 1):S1-42-6. PubMed ID: 19484874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Snake antivenom product guidelines in India: "the devil is in the details".
    Simpson ID; Norris RL
    Wilderness Environ Med; 2007; 18(3):163-8. PubMed ID: 17896852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In Africa snake venom antivenins in short supply. Fatal risk for foreign tourists?].
    Mebs D
    MMW Fortschr Med; 2002 Sep; 144(37):57. PubMed ID: 12380345
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress in the characterization of venoms and standardization of antivenoms.
    WHO Offset Publ; 1981; (58):1-44. PubMed ID: 7245916
    [No Abstract]   [Full Text] [Related]  

  • 35. Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context.
    Brown NI
    PLoS Negl Trop Dis; 2012; 6(6):e1670. PubMed ID: 22679521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Snake venoms and antivenoms: critical supply issues.
    Bawaskar HS
    J Assoc Physicians India; 2004 Jan; 52():11-3. PubMed ID: 15633710
    [No Abstract]   [Full Text] [Related]  

  • 37. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product--'what's in a name?'.
    Warrell DA
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):397-9. PubMed ID: 18359053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.
    Gutiérrez JM; Burnouf T; Harrison RA; Calvete JJ; Kuch U; Warrell DA; Williams DJ;
    Bull World Health Organ; 2014 Jul; 92(7):526-32. PubMed ID: 25110378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antivenoms needed, say officials, but companies won't bite.
    Hutson S
    Nat Med; 2010 Jun; 16(6):615. PubMed ID: 20526295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.